Indapamid Stada (Indapamide)

Indapamide inhibits the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney, reducing reabsorption of these electrolytes. This promotes increased urinary excretion of water and salts, decreasing plasma volume and producing a direct vasodilatory effect that together lower systemic blood pressure.

The appropriate dose of indapamide is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Dosage instructions are provided on the prescription label and should be followed exactly as directed by the healthcare professional.

Indapamide is classified as pregnancy category B, indicating that animal studies have not shown risk but there are no adequate human studies. It should be used during pregnancy only if the potential benefit justifies the potential risk. Limited data are available for breastfeeding, so a risk‑benefit assessment is required.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Indapamid Stada. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide belongs to the thiazide‑like class, offering a longer duration of action and a lower incidence of metabolic side effects compared with classic thiazides such as hydrochlorothiazide. It provides effective blood‑pressure control while often requiring a lower dose, but individual response and tolerance vary, so clinicians choose based on patient profile.

Store at ambient temperature: keep the tablets in the original packaging, protect them from moisture and light, and store them below 25 °C. Do not use the product if the packaging is damaged or if the tablets appear discoloured.

Indapamid Stada is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the specific instructions on the prescription label and maintain consistent timing each day to ensure stable blood‑pressure control.

Serious risks include severe dehydration, significant electrolyte disturbances such as hyponatremia or hypokalemia that can lead to cardiac arrhythmias, gout attacks, and rare allergic reactions like angioedema. Patients should seek immediate medical attention if they experience symptoms such as rapid weight loss, muscle weakness, severe abdominal pain, or swelling of the face or throat.

Indapamid Stada should be avoided in patients with known hypersensitivity to indapamide or other sulfonamide diuretics, in those with severe renal impairment, and in individuals with anuria. Caution is also advised for patients with gout, severe electrolyte imbalances, or uncontrolled diabetes, and the drug should only be used under medical guidance in these cases.